Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05508984 · ClinicalTrials.gov registry record
Clinical Outcomes and Patient Satisfaction With Use of the Amma System
A clinical trial of Breast Cancer, sponsored by Providence Health & Services.
- Active
- Registry status
- 15
- Enrollment target
- 3
- Study locations
NCT05508984 is a study of Breast Cancer that is active but no longer recruiting, run by Providence Health & Services. The registered enrollment target is 15 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05508984, a study of Breast Cancer, is active but no longer recruiting, sponsored by Providence Health & Services.
- ACTIVE NOT RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary goal is to conduct a pilot evaluation of the Amma device, to determine whether it is feasible to offer as an option for patients within oncology suites within the PH\&S system.
Conditions Studied
Interventions
- DEVICE Amma Cooling Caps
Study Locations (3)
Oregon
- Providence Cancer Institute - Newberg Clinic - Newberg
- Providence Portland Medical Center - Portland
- Providence Oncology and Hematology Care - Westside - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-22 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05508984
The ClinicalTrials.gov registry entry for NCT05508984 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Amma Cooling Caps is the first listed.
NCT05508984 reports 3 study locations spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT05508984 about?
NCT05508984 is a clinical study titled "Clinical Outcomes and Patient Satisfaction With Use of the Amma System". The primary goal is to conduct a pilot evaluation of the Amma device, to determine whether it is feasible to offer as an option for patients within oncology suites within the PH\&S system.
What is the current status of trial NCT05508984?
This trial is currently active not recruiting. The enrollment target is 15 participants. The study started on 2022-08-22. Estimated completion is 2025-12.
What conditions does trial NCT05508984 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05508984?
The interventions under investigation include: Amma Cooling Caps (DEVICE).
Who is sponsoring clinical trial NCT05508984?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05508984 being conducted?
This trial has 3 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.